{"hands_on_practices": [{"introduction": "A core task in pre-surgical psychological assessment is to systematically evaluate a candidate's psychosocial risk factors. To move beyond subjective impressions, clinicians often use structured instruments that translate patient data into a quantitative risk score. This first exercise walks you through the mechanics of a widely used tool, demonstrating how individual observations are weighted and combined to produce a final risk classification. By completing this practice, you will gain a concrete understanding of how complex patient information is synthesized into a single, actionable data point used in clinical decision-making [@problem_id:4737571].", "problem": "A hospital transplant psychology team uses the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) to quantify preoperative psychosocial risk for a kidney transplant candidate. A composite psychosocial risk score $S$ is constructed from four domains whose contributions are additive, reflecting the measurement principle that independent risk components combine linearly. Each domain is measured by items rated on an anchored scale, and each domain is assigned an empirically derived weight that reflects its relative influence on clinical outcomes such as adherence, relapse, and post-transplant adjustment. The domains and weights are as follows:\n\n- Patient’s Readiness (PR): $w_{\\mathrm{PR}} = 1$.\n- Social Support (SS): $w_{\\mathrm{SS}} = 1$.\n- Psychological Stability and Psychopathology (PSY): $w_{\\mathrm{PSY}} = 2$.\n- Lifestyle, Substance Use, and Adherence (LS): $w_{\\mathrm{LS}} = 2$.\n\nWithin each domain, items are scored on an anchored ordinal scale with integer values from $0$ to $3$, where higher values reflect greater psychosocial risk load for that item. The composite score follows the additive model $S = w_{\\mathrm{PR}} \\cdot R_{\\mathrm{PR}} + w_{\\mathrm{SS}} \\cdot R_{\\mathrm{SS}} + w_{\\mathrm{PSY}} \\cdot R_{\\mathrm{PSY}} + w_{\\mathrm{LS}} \\cdot R_{\\mathrm{LS}}$, where $R_{\\mathrm{Domain}}$ is the sum of item ratings within that domain.\n\nRisk categories used by the team are:\n- Low psychosocial risk if $S \\leq 30$.\n- Moderate psychosocial risk if $31 \\leq S \\leq 60$.\n- High psychosocial risk if $S \\geq 61$.\n\nFor this candidate, the item ratings assigned by the evaluator are:\n\nPatient’s Readiness (PR; $5$ items): understanding of procedure $= 3$, health literacy $= 2$, treatment adherence history $= 3$, motivation for transplant $= 1$, decisional capacity $= 2$.\n\nSocial Support (SS; $4$ items): presence of reliable caregiver $= 3$, stability of caregiving plan $= 2$, financial/transportation resources $= 2$, community support engagement $= 1$.\n\nPsychological Stability and Psychopathology (PSY; $5$ items): current mood symptoms $= 1$, anxiety symptoms $= 2$, history of severe mental illness $= 1$, trauma-related symptoms $= 2$, psychiatric treatment engagement $= 1$.\n\nLifestyle, Substance Use, and Adherence (LS; $6$ items): nicotine use $= 2$, alcohol use $= 3$, other substances $= 2$, dietary adherence $= 3$, appointment attendance $= 1$, medication management $= 2$.\n\nCompute the SIPAT composite score $S$ for this candidate using the specified weighting model, and determine the corresponding risk category based on the thresholds above. Report the numerical value of $S$. No rounding is required; provide the exact integer value.", "solution": "The problem statement is evaluated to be valid. It is scientifically grounded in the principles of psychometric assessment, specifically the use of a weighted linear model to form a composite score from sub-domain ratings, which is a standard methodology in medical psychology. The problem is well-posed, providing all necessary data—the scoring model, domain weights, individual item ratings, and risk classification thresholds—to arrive at a single, unambiguous answer. The language is objective and the data are internally consistent.\n\nThe task is to compute the composite psychosocial risk score, $S$, and determine the corresponding risk category for a kidney transplant candidate. The score is calculated using the specified additive model:\n$$S = w_{\\mathrm{PR}} \\cdot R_{\\mathrm{PR}} + w_{\\mathrm{SS}} \\cdot R_{\\mathrm{SS}} + w_{\\mathrm{PSY}} \\cdot R_{\\mathrm{PSY}} + w_{\\mathrm{LS}} \\cdot R_{\\mathrm{LS}}$$\nwhere $R_{\\mathrm{Domain}}$ represents the sum of item ratings within a domain and $w_{\\mathrm{Domain}}$ is the corresponding weight.\n\nFirst, we must calculate the sum of the item ratings for each of the four domains based on the data provided for the candidate.\n\nFor the Patient’s Readiness (PR) domain, which has $5$ items, the ratings are $3$, $2$, $3$, $1$, and $2$. The sum is:\n$$R_{\\mathrm{PR}} = 3 + 2 + 3 + 1 + 2 = 11$$\n\nFor the Social Support (SS) domain, which has $4$ items, the ratings are $3$, $2$, $2$, and $1$. The sum is:\n$$R_{\\mathrm{SS}} = 3 + 2 + 2 + 1 = 8$$\n\nFor the Psychological Stability and Psychopathology (PSY) domain, which has $5$ items, the ratings are $1$, $2$, $1$, $2$, and $1$. The sum is:\n$$R_{\\mathrm{PSY}} = 1 + 2 + 1 + 2 + 1 = 7$$\n\nFor the Lifestyle, Substance Use, and Adherence (LS) domain, which has $6$ items, the ratings are $2$, $3$, $2$, $3$, $1$, and $2$. The sum is:\n$$R_{\\mathrm{LS}} = 2 + 3 + 2 + 3 + 1 + 2 = 13$$\n\nNext, we substitute these domain scores into the composite score formula using the specified weights: $w_{\\mathrm{PR}} = 1$, $w_{\\mathrm{SS}} = 1$, $w_{\\mathrm{PSY}} = 2$, and $w_{\\mathrm{LS}} = 2$.\n$$S = (1 \\cdot R_{\\mathrm{PR}}) + (1 \\cdot R_{\\mathrm{SS}}) + (2 \\cdot R_{\\mathrm{PSY}}) + (2 \\cdot R_{\\mathrm{LS}})$$\n$$S = (1 \\cdot 11) + (1 \\cdot 8) + (2 \\cdot 7) + (2 \\cdot 13)$$\n$$S = 11 + 8 + 14 + 26$$\nPerforming the addition:\n$$S = 19 + 14 + 26$$\n$$S = 33 + 26$$\n$$S = 59$$\nThe calculated SIPAT composite score is $S=59$.\n\nFinally, we determine the risk category by comparing this score to the given thresholds:\n- Low psychosocial risk: $S \\leq 30$\n- Moderate psychosocial risk: $31 \\leq S \\leq 60$\n- High psychosocial risk: $S \\geq 61$\n\nSince the computed score is $S=59$, it falls within the range $31 \\leq 59 \\leq 60$. Therefore, the candidate is classified as having a Moderate psychosocial risk. The problem asks for the numerical value of $S$.", "answer": "$$\\boxed{59}$$", "id": "4737571"}, {"introduction": "Simply knowing a screening tool's accuracy is not enough; its true value depends on the specific population in which it is used. A test that seems powerful in a research setting may perform differently in a real-world clinic where the prevalence of a condition is low. This practice delves into the critical concepts of predictive value, using fundamental principles of probability to determine a tool's real-world utility [@problem_id:4737631]. Mastering this calculation is essential for any practitioner who wants to critically evaluate assessment tools rather than using them blindly, ensuring that screening results are interpreted responsibly.", "problem": "A hospital-based bariatric surgery program uses a psychosocial screening tool to flag candidates at elevated risk for postoperative nonadherence to medical recommendations. In the evaluated population, the prevalence of clinically significant nonadherence risk is $p=0.25$. Independent validation of the tool reports sensitivity $0.80$ and specificity $0.90$ for detecting this elevated risk status.\n\nStarting from the fundamental definitions of conditional probability and Bayes theorem, derive closed-form expressions for the positive predictive value (PPV) and negative predictive value (NPV) of the tool in terms of $p$, sensitivity, and specificity, and then compute their numerical values for the given parameters. Briefly interpret the clinical utility of this tool for preoperative decision-making in this setting, referencing the computed quantities and standard diagnostic reasoning.\n\nRound your final reported PPV to four significant figures and express it as a decimal (not a percentage). Your final answer must be a single number.", "solution": "The problem is assessed to be valid. It is scientifically grounded in the established principles of diagnostic test evaluation, including sensitivity, specificity, and predictive values, which are derived from Bayes' theorem. The problem is well-posed, providing all necessary data ($p=0.25$, sensitivity$=0.80$, specificity$=0.90$) for a unique solution. The language is objective and the parameters are realistic for a clinical screening context.\n\nLet $R$ denote the event that a surgical candidate is truly at elevated risk for nonadherence. Let $R^c$ denote the complement event, that the candidate is not at elevated risk. Let $T$ represent the event of a positive test result (the tool flags the candidate), and $T^c$ be the event of a negative test result.\n\nFrom the problem statement, we are given the following probabilities:\nThe prevalence of elevated risk is $P(R) = p = 0.25$.\nThe probability of not being at elevated risk is $P(R^c) = 1 - P(R) = 1 - p = 1 - 0.25 = 0.75$.\nThe sensitivity of the tool is the probability of a positive test given the presence of risk: $P(T|R) = 0.80$.\nThe specificity of the tool is the probability of a negative test given the absence of risk: $P(T^c|R^c) = 0.90$.\n\nFrom these, we can deduce two other conditional probabilities:\nThe false negative rate is the probability of a negative test despite the presence of risk: $P(T^c|R) = 1 - P(T|R) = 1 - 0.80 = 0.20$.\nThe false positive rate is the probability of a positive test despite the absence of risk: $P(T|R^c) = 1 - P(T^c|R^c) = 1 - 0.90 = 0.10$.\n\nThe task is to derive expressions for the positive predictive value (PPV) and negative predictive value (NPV).\n\nThe positive predictive value, PPV, is the probability that a candidate is truly at risk given a positive test result, i.e., $P(R|T)$. Using Bayes' theorem, this is expressed as:\n$$ \\text{PPV} = P(R|T) = \\frac{P(T|R) P(R)}{P(T)} $$\nThe denominator, $P(T)$, is the total probability of a positive test. It can be expanded using the law of total probability:\n$$ P(T) = P(T|R)P(R) + P(T|R^c)P(R^c) $$\nSubstituting this into the Bayes' theorem expression gives the closed-form for PPV:\n$$ \\text{PPV} = \\frac{P(T|R)P(R)}{P(T|R)P(R) + P(T|R^c)P(R^c)} $$\nIn terms of the given parameters, this is:\n$$ \\text{PPV} = \\frac{(\\text{sensitivity}) \\cdot p}{(\\text{sensitivity}) \\cdot p + (1 - \\text{specificity}) \\cdot (1 - p)} $$\n\nThe negative predictive value, NPV, is the probability that a candidate is truly not at risk given a negative test result, i.e., $P(R^c|T^c)$. Using Bayes' theorem again:\n$$ \\text{NPV} = P(R^c|T^c) = \\frac{P(T^c|R^c) P(R^c)}{P(T^c)} $$\nThe denominator, $P(T^c)$, is the total probability of a negative test, expanded as:\n$$ P(T^c) = P(T^c|R^c)P(R^c) + P(T^c|R)P(R) $$\nSubstituting this gives the closed-form for NPV:\n$$ \\text{NPV} = \\frac{P(T^c|R^c)P(R^c)}{P(T^c|R^c)P(R^c) + P(T^c|R)P(R)} $$\nIn terms of the given parameters, this is:\n$$ \\text{NPV} = \\frac{(\\text{specificity}) \\cdot (1 - p)}{(\\text{specificity}) \\cdot (1 - p) + (1 - \\text{sensitivity}) \\cdot p} $$\n\nNow, we compute the numerical values for the given parameters:\n$p=0.25$, sensitivity $= 0.80$, and specificity $= 0.90$.\n$1 - p = 0.75$, $1 - \\text{sensitivity} = 0.20$, $1 - \\text{specificity} = 0.10$.\n\nFor the PPV:\n$$ \\text{PPV} = \\frac{(0.80) \\cdot (0.25)}{(0.80) \\cdot (0.25) + (0.10) \\cdot (0.75)} = \\frac{0.20}{0.20 + 0.075} = \\frac{0.20}{0.275} = \\frac{200}{275} = \\frac{8}{11} $$\nAs a decimal, $\\frac{8}{11} \\approx 0.727272...$. Rounded to four significant figures, $\\text{PPV} = 0.7273$.\n\nFor the NPV:\n$$ \\text{NPV} = \\frac{(0.90) \\cdot (0.75)}{(0.90) \\cdot (0.75) + (0.20) \\cdot (0.25)} = \\frac{0.675}{0.675 + 0.05} = \\frac{0.675}{0.725} = \\frac{675}{725} = \\frac{27}{29} $$\nAs a decimal, $\\frac{27}{29} \\approx 0.931034...$. So, $\\text{NPV} \\approx 0.9310$.\n\nClinical Utility Interpretation:\nThe calculated $\\text{PPV}$ of approximately $0.73$ indicates that when the tool flags a candidate as high-risk, there is a $73\\%$ chance they truly are at high risk. While this is substantially better than the baseline prevalence of $25\\%$, it also means that about $27\\%$ of positive results are false alarms ($1 - \\text{PPV}$). Therefore, a positive screening result should not be used for definitive exclusion but rather to triage candidates for a more comprehensive psychological evaluation.\nThe calculated $\\text{NPV}$ of approximately $0.93$ is very high. This means that if a candidate receives a negative test result, there is a $93\\%$ probability that they are genuinely at low risk for nonadherence. The tool is thus highly effective at \"ruling out\" risk. From a clinical resource allocation perspective, this is extremely useful. Clinicians can be confident that the vast majority of patients who screen negative do not require further intensive psychosocial scrutiny, allowing them to focus resources on the smaller, enriched population identified by positive screens. The tool's primary utility in this setting is its strong performance in identifying low-risk individuals.", "answer": "$$\n\\boxed{0.7273}\n$$", "id": "4737631"}, {"introduction": "The most challenging and crucial aspect of medical psychology is untangling the complex interplay between mind and body. In patients with severe medical illness, symptoms like fatigue, poor sleep, and low mood can stem from the illness itself, its treatments, or a primary psychiatric condition. This final practice presents a realistic clinical vignette that requires you to act as a diagnostic detective. You must synthesize a wide range of data—from laboratory results to validated screening scores—to formulate a differential diagnosis and develop a safe and appropriate management plan, highlighting the principle that medical causes must always be considered first [@problem_id:4737746].", "problem": "A candidate for kidney transplant is undergoing pre-transplant psychological assessment. The patient is a $52$-year-old male with Chronic Kidney Disease (CKD) stage $4$ due to diabetic nephropathy, with an estimated glomerular filtration rate (eGFR) of $22$ $\\mathrm{mL/min/1.73\\,m^2}$. Over the last $3$ months, he reports progressive fatigue, unrefreshing sleep, and low mood. He describes sleep fragmentation with approximately $5$ hours of sleep per night, loud snoring, and his partner has witnessed pauses in breathing. He denies suicidal ideation, psychomotor retardation, or pervasive anhedonia; he continues to enjoy watching soccer but feels “discouraged about dialysis and the future.” Appetite is unchanged and weight is stable. He notes that symptoms are worse on post-dialysis days. Past psychiatric history is negative. Current medications include an angiotensin-converting enzyme inhibitor, insulin, and gabapentin. Alcohol use is minimal and he denies opioid use. Vital signs include blood pressure $140/85$ $\\mathrm{mmHg}$. Laboratory results show hemoglobin $9.6$ $\\mathrm{g/dL}$, ferritin $160$ $\\mathrm{ng/mL}$, transferrin saturation $22$ $\\%$, thyroid-stimulating hormone $2.1$ $\\mathrm{\\mu IU/mL}$. Patient Health Questionnaire ($\\mathrm{PHQ}\\text{-}9$) score is $10$ with endorsement of low mood, sleep disturbance, fatigue, and concentration difficulties, but no suicidal ideation. The Snoring, Tiredness, Observed apnea, high blood Pressure, Body mass index, Age, Neck circumference, Gender (STOP-Bang) screening yields: snoring (yes), daytime tiredness (yes), observed apneas (yes), high blood pressure (yes), body mass index $37$ $\\mathrm{kg/m^2}$ (yes), age $>$ $50$ (yes), neck circumference $42$ $\\mathrm{cm}$ (yes), male gender (yes), for a total score of $8$.\n\nYou are asked to determine the most appropriate differential diagnosis and treatment plan before granting psychological clearance. Use the following fundamental bases from medical psychology and behavioral medicine:\n\n- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-$5$) criteria for a Major Depressive Episode: a syndrome defined by at least $5$ symptoms including depressed mood or anhedonia for at least $2$ weeks, causing clinically significant distress or impairment, and not better explained by a substance or another medical condition.\n- The principle of ruling out medical etiologies that can produce overlapping symptom clusters (for example, anemia, sleep-disordered breathing, hypothyroidism), and addressing modifiable contributors before labeling a primary psychiatric disorder.\n- Validated screening tools: Patient Health Questionnaire ($\\mathrm{PHQ}\\text{-}9$) severity thresholds (scores $5$–$9$ mild, $10$–$14$ moderate, $15$–$19$ moderately severe, $\\geq$ $20$ severe), and STOP-Bang score $\\geq$ $3$ indicating high risk for Obstructive Sleep Apnea (OSA).\n- Pre-transplant psychological clearance principles: identify and mitigate modifiable risks to adherence and postoperative recovery, ensure stability of mood and sleep sufficient for reliable participation in complex care, and avoid introducing perioperative risks (for example, excessive sedation from benzodiazepines).\n\nWhich option best integrates the differential diagnosis and specifies an appropriate pre-transplant management plan?\n\nA. Diagnose Major Depressive Disorder; initiate sertraline at a renally adjusted dose immediately; grant psychological clearance now because pharmacotherapy will address depressive symptoms, and no further sleep or medical evaluation is necessary.\n\nB. Diagnose Adjustment Disorder with depressed mood with probable comorbid Obstructive Sleep Apnea and anemia contributing to fatigue and sleep disturbance; order overnight polysomnography and initiate Continuous Positive Airway Pressure (CPAP) if indicated, coordinate with nephrology to optimize erythropoiesis-stimulating agent and iron management, provide brief cognitive-behavioral therapy focused on coping and sleep hygiene, and re-evaluate mood and sleep after $4$–$6$ weeks prior to granting clearance.\n\nC. Diagnose demoralization only; provide reassurance without additional workup; grant psychological clearance today because low mood is expected in CKD and does not require intervention.\n\nD. Diagnose Depressive Disorder due to another medical condition with high suicide risk; defer transplant listing; start a benzodiazepine for sleep and refer for inpatient psychiatric admission.\n\nE. Diagnose Substance-Induced Depressive Disorder secondary to opioid use; taper opioids and grant immediate clearance after $1$ week given the reversible etiology.", "solution": "The problem requires a differential diagnosis and management plan for a kidney transplant candidate with a complex presentation of mood, sleep, and fatigue symptoms. The core principle is to first rule out or address medical conditions that can explain the symptoms before diagnosing a primary psychiatric disorder.\n\n1.  **Analysis of Patient Data**:\n    *   **Symptoms**: The patient presents with low mood, fatigue, sleep disturbance, and concentration difficulties, resulting in a $\\mathrm{PHQ}\\text{-}9$ score of $10$ (moderate depressive symptoms). However, key features of Major Depressive Disorder, such as pervasive anhedonia and psychomotor retardation, are absent. This suggests the symptoms may stem from other causes.\n    *   **Medical Etiologies**: There is strong evidence for at least two major medical contributors to his symptoms:\n        *   **Obstructive Sleep Apnea (OSA)**: The STOP-Bang score is $8$, the maximum possible score, indicating a very high probability of severe OSA. A score $\\geq 3$ is considered high risk. The patient's reported symptoms (snoring, witnessed apneas, daytime tiredness) are classic for OSA, which is a known cause of fatigue, mood changes, and cognitive impairment.\n        *   **Anemia of Chronic Disease**: The patient's hemoglobin is $9.6$ $\\mathrm{g/dL}$, indicating clinically significant anemia, a common complication of CKD and a primary driver of fatigue. The normal TSH level ($2.1$ $\\mathrm{\\mu IU/mL}$) rules out hypothyroidism.\n    *   **Diagnostic Conclusion**: According to the DSM-$5$ criteria, a depressive disorder should not be diagnosed if the symptoms are better explained by another medical condition. In this case, the combination of high-probability severe OSA and anemia provides a compelling medical explanation for the patient's symptom cluster. The low mood is best characterized as an Adjustment Disorder with depressed mood, representing a psychological reaction to his serious medical illness.\n\n2.  **Evaluation of Management Options**:\n    *   **Option A** is incorrect. It prematurely diagnoses Major Depressive Disorder and initiates an antidepressant without addressing the likely underlying medical causes (OSA and anemia). Granting immediate clearance is unsafe with these unmanaged risks.\n    *   **Option C** is incorrect. It recognizes the low mood but is negligent in failing to work up the extremely high-risk STOP-Bang score and clinically significant anemia. Untreated severe OSA is a major cardiovascular risk factor, which is unacceptable in a transplant candidate.\n    *   **Option D** is incorrect. It misidentifies the suicide risk as high, which is contradicted by the problem statement. Furthermore, prescribing a benzodiazepine is contraindicated in untreated OSA, as it can worsen respiratory depression.\n    *   **Option E** is incorrect as it is based on a false premise; the patient denies opioid use.\n    *   **Option B** is the most appropriate choice. It correctly frames the diagnosis as an Adjustment Disorder with contributing medical factors. The management plan is logical and safe: (1) confirm and treat the probable severe OSA with polysomnography and CPAP, (2) coordinate with nephrology to manage the anemia, (3) provide supportive psychotherapy (CBT), and (4) prudently re-evaluate the patient's stability after these interventions *before* granting final psychological clearance. This approach directly addresses the modifiable medical risks to optimize the candidate's safety and chance of a successful transplant outcome.", "answer": "$$\\boxed{B}$$", "id": "4737746"}]}